期刊文献+

补肾壮骨中药对成骨细胞OPG、RANKL mRNA表达的影响 被引量:7

The effect of traditional Chinese medicine on the expression of mRNA of OPG and RANKL
原文传递
导出
摘要 目的观察补肾壮骨中药对成骨细胞OPG和RANKL的影响,探讨中药对牵张成骨作用机制。方法 Beagle犬6只,雄性,体重10kg^15kg。实验分为含药血清组(A组)、无药血清组(B组)和胎牛血清组(C组)。含药血清组的血清来自补肾壮骨中药经煎制后,按体表面积折算等效剂量,2只Beagle犬连续喂服7天后经股动脉采血制备而成。无药血清组的血清采用等剂量生理盐水2只Beagle犬喂服7天后经股动脉采血制备而成。胎牛血清组的血清直接购买。另外2只Beagle犬由胫骨获取骨髓,经F icoll分离液进行梯度离心,MSC经含胎牛血清的DMEM培养,传代后分别将MSC在含药血清(A组)、无药血清(B组)和胎牛血清(C组)的诱导矿化液(β-甘油磷酸钠,维生素C和地塞米松)+DMEM中培养。采用原位杂交的方法检测成骨细胞OPG和RANKL mRNA的表达情况。结果诱导培养5天、7天时,含药血清组成骨细胞OPG mRNA的表达量均高于无药血清组和胎牛血清组(P<0.05)。无药血清组和胎牛血清组相比无显著性差异(P>0.05)。诱导培养5天时,成骨细胞RANKLmRNA的表达量三组间两两比较均无显著性差异(P>0.05)。诱导培养7天时,含药血清组成骨细胞OPG mRNA的表达量均低于无药血清组和胎牛血清组(P<0.05)。无药血清组和胎牛血清组相比无显著性差异(P>0.05)。诱导培养5天时,含药血清组OPG/RANKL比率是无药血清组的1.67倍,是胎牛血清组的2.01倍。诱导培养7天时,含药血清组OPG/RANKL比率是无药血清组的2.18倍,是胎牛血清组的2.62倍。结论补肾壮骨中药可以调节成骨细胞分泌OPG、RANKL的功能,从而降低破骨细胞的活力,促进成骨过程。 Objective To observe the effect of traditional Chinese medicine on the expression of OPG and RANKL and to investigate the mechanism of distracting osteogenesis.Methods Six male Beagle dogs,each weighed 10kg~15kg,were divided into three groups: group A medicine serum group,group B non-medicine serum group and group C bovine serum group respectively.The serum of group A was obtained from the femoral artery of 2 Beagle dogs that had been given equivalent dose of traditional Chinese medicine for 7 days continuously according to body surface area.The serum of group B was also collected from the femoral artery of 2 Beagle dogs fed with equal volume of normal saline water for 7 days continuously.The serum of group C was bought fetal bovine serum.The tibia marrow was harvested from another 2 Beagle dogs and MSCs were isolated and purified by density gradient centrifugation.Then MSCs were cultured in DMEM solution with fetal bovine serum.MSCs of the 3rd generation were cultured in DMED medium with mineralization inducing liquid containing medicine serum(group A),non-medicine serum(group B) and bovine serum(group C) respectively.The expression of osteoblast OPG and RANKL mRNA were detected by situ hybridization method.Results After induced culturing for 5 days and 7 days,the expression levels of osteoblasts OPG mRNA of medicine serum group was higher than that of non-medicine serum group and bovine serum group(P0.05).But non-medicine serum group and bovine serum group showed no significant difference(P0.05).After induced culturing for 5 days,the expression levels of osteoblasts RANKL mRNA of the three groups had no significant differences(P0.05).After induced culturing for 7 days,the expression levels of osteoblasts RANKL mRNA of medicine serum group were less than that of non-medicine serum and bovine serum(P0.05).But non-medicine serum group and bovine serum group showed no significant difference(P0.05).After induced culturing for 5 days,OPG/RANKL ratio of medicine serum group was 1.67 compared with non-medicated serum group and 2.01 compared with bovine serum group.After induced culturing for 7 days,OPG / RANKL ratio of medicine serum was 2.18 compared with non-medicine group and 2.62 compared with bovine serum group.Conclusion The traditional Chinese medicine can promote the synthesis of osteoblast OPG,inhibit the release of osteoblast RANKL,and increase OPG/ RANKL ratio,then reduce the vitality of osteoclasts and promote the forming of new bone.
出处 《现代口腔医学杂志》 CAS CSCD 2011年第3期194-198,共5页 Journal of Modern Stomatology
基金 河北省自然科学基金项目(C2007000814) 河北省科学技术研究与发展指令计划项目(06276102D-111)
关键词 BEAGLE犬 补肾壮骨中药 骨髓间充质干细胞 骨保护素(OPG) 细胞核因子κβ受体 活化因子配体(RANKL) Beagle dog Chinese tradition medicine Mesenchymal stem cells Osteoprotegerin(OPG) Receptor activator of nuclear factor-κB ligand(RANKL)
  • 相关文献

参考文献11

  • 1任贵云,赵虎,董福生,董玉英,石培凯,郝福良,李建英.活血化淤补肾壮骨中药促进山羊下颌骨牵张成骨的实验研究[J].实用口腔医学杂志,2009,25(3):319-322. 被引量:9
  • 2鞠大宏,刘梅洁,赵宏艳,潘静华,刘红,张立石,于智敏,王燕平,于峥,贾朝娟,赵涛.左归丸含药血清对成骨细胞OPG、RANKL mRNA表达的影响[J].北京中医药大学学报,2008,31(5):312-315. 被引量:28
  • 3闫宝勇,董福生,王洁,郝福良,董玉英,胡启慧.中药对犬骨髓干细胞成骨分化增殖的影响[J].中华口腔医学杂志,2010,45(1):31-35. 被引量:4
  • 4Kong YY, Feige U, Sarosi I, et al. Activated T ceils regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature, 1999, 402 : 304 - 309.
  • 5Burgess TL, Qian Y, Kaufinan S, et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol, 1999, 145(3) : 527 -538.
  • 6Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997, 89(2): 309-319.
  • 7Clohisy D. Cellular mechanisms of osteolysis. J Bone Joint Surg Am, 2003, 85 - A Suppl 1 : S4 - 6.
  • 8Theoleyre S, Wittrant Y, Tat SK, et al. The molecular triad OPG/ RANK/RANKL: involvement in the orchestration of pathophysiological hone remodeling. Cytokine Growth Factor Rev, 2004, 15 (6) : 457 - 475.
  • 9张建兴,黄生高.护骨素、破骨细胞分化因子系统与牙槽骨改建[J].国际口腔医学杂志,2006,33(4):303-305. 被引量:4
  • 10Kong YY, Yoshida H, Sarosi I, et ah OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph - node organogenesis. Nature, 1999, 397 : 315 - 323.

二级参考文献70

共引文献49

同被引文献92

引证文献7

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部